Moreover, adenoviral delivery of S100A1 was effective in the treatment of heart failure in small and large animals and improving the failing function of animal and human cardiomyocytes (Pleger et al. 2007, 2011; Brinks et al. 2011). This evidence concerns the gene S100A1 and heart failure.